Oct. 15, 2024 — Alzheimer's disease may damage the brain in two distinct phases, based on new research using sophisticated brain mapping tools. According to researchers who discovered this new ...

Includes reviews of Impex Auto Sales from DealerRater. Want to share your experience with this dealership? Everyone there was very easy to deal with. Ben gave me exceptional service and was a ...

Researchers do not believe Alzheimer’s disease has one specific cause. Instead, a combination of genetic, environmental, and lifestyle risk factors can contribute to the condition. Alzheimer’s ...

When Dennis Carr learned he had early Alzheimer’s disease, he immediately thought of his older brother who had died of the illness in 2023. “There was not much anyone could do,” Carr said of ...

Early observations suggest that the vehicle-treated Alzheimer's mice exhibit a larger population of reactive astrocytes, while the HT-ALZ treated groups show fewer reactive astrocytes, pointing to ...

A new study highlights the potential of using smartphone data collected in real-world situations for the early detection of cognitive decline in older adults. The 'Enormous' Promise of Focused ...

21, which is also World Alzheimer's Day Bettina Strauss/Hallmark Media Ashley Williams’s new Hallmark movie, Falling Together, didn’t start as an homage to her mother, Linda, who died from ...

Dr. Susan Aguiñaga from the College of Applied Health Sciences joined WCIA's Taylor Mitchell on World Alzheimer's Day to discuss her research with the disease.

Scientists may have uncovered a new mechanism for treating Alzheimer's disease, offering hope to millions of patients worldwide. The discovery involves the activation of the brain's cellular clean ...

Alzheimer's disease is a progressive neurodegenerative disease that impairs memory and cognitive judgment and is often accompanied by mood swings, disorientation and eventually delirium. It is the ...

Moreover, the researchers uncovered microRNA candidate molecular biomarkers that associate with current Amyloid, Tau, and Neurodegeneration (A/T/N) Alzheimer's biomarkers. The failure to diagnose ...

Such is the case with newly approved Bristol-Myers Squibb drug Cobenfy. The underlying drug was first studied in Alzheimer’s patients in the 1990s, but it was abandoned because of severe side ...